TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT mutations in medulloblastoma have not been described. Hence, we sought to describe...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | anglais |
Publié: |
2013
|
Accès en ligne: | https://doi.org/10.1007/s00401-013-1198-2 https://link.springer.com/content/pdf/10.1007/s00401-013-1198-2.pdf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|